03/02/2010
OSI Pharmaceuticals Board of Directors to Review Astellas' Unsolicited Tender Offer
03/01/2010
OSI Pharmaceuticals Confirms Receipt of Unsolicited Proposal From Astellas Pharma
If you are a member of the media, please call our Corporate Relations department:
| Kathy Galante Senior Director, Investor and Public Relations Phone: 631-962-2043 Email: kgalante@osip.com |
Kim Wittig Director, Public Relations Phone: 631-962-2135 Email: kwittig@osip.com |